trending Market Intelligence /marketintelligence/en/news-insights/trending/0cBjnB0z1eCGAXypHhnLTw2 content esgSubNav
In This List

Hangzhou Just Biotherapeutics closes $57M financing

Blog

Top 100 Banks: Capital Ratios Show Resilience to the Pandemic

Blog

Banking Essentials Newsletter: October Edition

Blog

Banking Essentials Newsletter: September Edition, Part - 2

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage


Hangzhou Just Biotherapeutics closes $57M financing

Hangzhou Just Biotherapeutics Ltd. closed a $57 million series B financing led by Temasek Holdings (Pte) Ltd. (Unspecified Vehicle) and existing investors Lilly Asia Ventures and ARCH Venture Partners LLC.

New investors in the round included Taikang, Hangzhou Economic & Technological Development Area, Bank of China and Bank of Hangzhou.

The funds will be used to advance the company's product pipeline and to complete a research and manufacturing facility in China.